California Department of Justice suing pharmaceutical companies over high insulin costs

  • 📰 latimes
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 82%

Business News News

Business Business Latest News,Business Business Headlines

California Atty. Gen. Rob Bonta said that Eli Lilly, Sanofi and Novo Nordisk are finding ways to “aggressively hike” the price of insulin at the expense of many patients.

The California Department of Justice is suing three of the nation’s largest insulin makers over the high cost of the drug, which diabetics need to survive.

The lawsuit, which was filed under the state’s unfair-competition law, also includes pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx as defendants. The companies serve as intermediaries between insurance and pharmaceutical companies.“No company is too big to skirt the law or too large to be held accountable,” Bonta said. “Big Pharma might negotiate drug prices, but as your attorney general, let me be unequivocally clear.

In its lawsuit, the state is seeking remedies that include barring the companies from overcharging patients and restitution for Californians who overpaid for insulin. In an emailed statement, a spokesperson for Eli Lilly said that the company “is disappointed by the California Attorney General’s false accusations.”

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

It was an honor to be at the announcement & for the opportunity to share my story. I am not unique, 1:4 report rationing their insulin while LillyPad sanofi & novonordisk reap unconscionable profits. This is a great step towards accountability & insulin4all

Lol

I thought this was fixed by Trump, then broken by Biden then kind of fixed by Biden...

Why not sue them over Covid vaccine injuries?

Good! It is ridiculous that insulin costs are exorbitant in only the USA. Pure corporate greed.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 11. in BUSİNESS

Business Business Latest News, Business Business Headlines